Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 24 Lung Neoplasms 14 Neoplasm Metastasis 12 Carcinoma, Medullary 12 Neoplasms 10 Thyroid Neoplasms 8 Breast Neoplasms 8 Glioma 6 Prostatic Neoplasms 5 Glioblastoma 5 Squamous Cell Carcinoma of Head and Neck 4 Gliosarcoma 4 Colorectal Neoplasms 4 Brain Neoplasms 4 Pancreatic Neoplasms 3 Ovarian Neoplasms 3 Head and Neck Neoplasms 3 Carcinoma, Renal Cell 3 Adenocarcinoma 3 Urinary Bladder Neoplasms 2 Thyroid Cancer, Papillary 2 Stomach Neoplasms 2 Recurrence 2 Rectal Neoplasms 2 Pleural Effusion 2 Kidney Neoplasms 2 Familial medullary thyroid carcinoma 2 Fallopian Tube Neoplasms 2 Esophageal Neoplasms 2 Disease Progression 2

Interventions

Oxaliplatin 29 Fluorouracil 25 Leucovorin 20 Capecitabine 18 Irinotecan 17 Bevacizumab 14 Cisplatin 12 Surveys and Questionnaires 11 Gemcitabine 9 Drug Therapy 9 Standard of Care 8 Nivolumab 7 Cetuximab 7 pembrolizumab 6 S 1 (combination) 6 Cyclophosphamide 6 atezolizumab 5 Specimen Handling 5 Endoscopic Mucosal Resection 5 Educational Status 5 Docetaxel 5 Blood Specimen Collection 5 fludarabine 4 aldesleukin 4 Radiotherapy 4 Radiosurgery 4 Pemetrexed 4 IFL protocol 4 Folfox protocol 4 Everolimus 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Gastrointestinal Neoplasms × vandetanib × Clear all

NCT02013089 2016-08-30

GITIC

Sun Yat-sen University

Phase NA Unknown

Gastrointestinal

Gastrointestinal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡